II. Pathophysiology
- Childhood Movement Disorder
- Occurs within 8 months of Streptococcal infection
- Specifically Group A Beta Hemolytic Streptococcus
- Late manifestation of Rheumatic Fever
III. Epidemiology
- Incidence: <5% of Rheumatic Fever cases
- Ages: 5 to 15 years
- Girls affected more often than boys
IV. Symptoms: Gradual onset of neurological symptoms
- Atypical behavior
- Irritability and crying
- Anxiety and restlessness
- Transient Acute Psychosis
- Poor memory retention
- Motor weakness
- Abrupt onset of choreoform movements (purposeless, nonrhythmic, involuntary) only present while awake
- Irregular and aimless
- Affects extremities, face and trunk
V. Signs
-
Choreiform movements
- Abrupt, purposeless, nonrhythmic involuntary movement
- Hyperextended joints
- Motor weakness
- Inaccurate voluntary motions
- Clumsiness
- Hypotonia
- Diminished Deep Tendon Reflexes
- Speech Impairment (Dysarthria)
- Asymmetric (one side usually more affected than other)
VI. Labs
- Strep Test or Throat Culture
- Negative in >50% of cases
- Cerebrospinal fluid
- Intracerebral pressure (opening pressure) increased
- CSF Glucose increased
- CSF Leukocyte count increased
- Late manifestation results in negative markers
- ASO Titer negative
- Acute phase reactants negative
VII. Management
- Evaluate for other manifestations of Rheumatic Heart Disease
- Initiate Penicillin
- Initial Treatment (often given regardless of Throat Culture result)
- Secondary Prophylaxis
- Medications
- Penicillin G 1.2 million units IM every 21 days
- Duration
- No Carditis: Administer for at least 5 years AND until age >18 years
- Mild Carditis: Administer for at least 10 years AND until age >21 years
- Moderate to severe carditis: Lifelong Penicillin prophylaxis
- Medications
- Mild to no functional Impairment
- No Chorea treatment needed
- Moderate to severe Impairment
- Step 1a: Anticonvulsant (choose one)
- Valproate 20 mg/kg/day OR
- Carbamazepine 15 mg/kg/day
- Step 1b: Adjunctive Corticosteroids (Indicated in severe or refractory cases, Chorea paralytica)
- Prednisone 2 mg/kg/day for 2-4 weeks, followed by taper OR
- Methylprednisolone 25 mg/kg/day IV for 5 days, followed by taper
- Step 2: Reevaluate response to anticonvulsants
- Improved: Wean as tolerated after 4 weeks symptom free
- Refractory: Go to Step 3
- Step 3: Refractory Management
- Add Antipsychotic (choose 1)
- Risperidone 1-2 mg orally twice daily (teen 0.5 mg twice daily in age 13-17 years) OR
- Olanzapine 5-10 mg/day orally (teen 2.5 to 5 mg/day in age 13 to 17 years) OR
- Haloperidol 5-10 mg orally every 6-8 hours (child 0.05 to 0.15 mg/kg up to 2-5 mg for teen) OR
- Pimozide 1-2 mg at bedtime (child 0.05 mg/kg up to 1 to 2 mg)
- Persistent refractory symptoms despite Antipsychotic and anticonvulsant
- Consider Corticosteroids (see Step 1b above)
- Consider experimental treatments
- IVIG 2 g/kg IV for 5 days
- Plasmapheresis for 5 days
- Add Antipsychotic (choose 1)
- Step 1a: Anticonvulsant (choose one)
VIII. Prognosis
- Self limited
- Expect improvement within 3 to 6 weeks (complete resolution by 2-3 years)